Wockhardt, which is reeling under heavy debt and is trying to deleverage its balance sheet, has agreed to sell multiple products and a manufacturing facility to Dr Reddy’s Laboratories. In a regulatory filing, Wockharrdt said Dr Reddy’s Labs will acquire 62 products and its unit in Baddi, Himachal Pradesh in a slump sale for a consideration of Rs 1,850 crore. — The Economic Times
Cyril Amarchand Mangaldas advised Wockhardt Limited led by a team of Transaction team was led by partner Ramgovind Kuruppath, and partner Gautam Gandotra, with support from senior associate Archit Bhatnagar, senior associate Arnav Shah, The Taxation team led by Daksha Baxi, Head International Taxation, with support from , principal associate Surajkumar Shetty, and senior associate Ankit Namdeo., The Competition Law team was led by partner Anshuman Sakle, with support from principal associate Kaustav Kundu.
Update 1 July 2020: Platinum Partners advised Dr Reddy's Laboratories Limited led by a team including partner Gautam Bhat, associate Unnati Divecha, associate Stuti Khosla, associate Abhimanyu Sharma, associate Shalini Panigrahi.
2020-02-12
Deal value: Rs 1850 crores; $259m
This deal report is based on a firm's press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.
Click here if you are working with a law firm that has not been credited for this deal, and we will update the report promptly.
Click to show comments
at your own risk
(alt+c)
By reading the comments you agree that they are the (often anonymous) personal views and opinions of readers, which may be biased and unreliable, and for which Legally India therefore has no liability. If you believe a comment is inappropriate, please click 'Report to LI' below the comment and we will review it as soon as practicable.
threads most popular
thread most upvoted
comment newest
first oldest
first
threads most popular
thread most upvoted
comment newest
first oldest
first